Quantitative Measurement of CD52 Expression and Alemtuzumab Binding in Adult Acute Lymphoblastic Leukemia (ALL): Correlation with Immunophenotype and Cytogenetics in Patients (Pts) Enrolled on a Phase I/II Trial from the Cancer and Leukemia Group B (CALGB 10102)
- Citation:
- Blood vol 110 (11) 2386
- Meeting Instance:
- ASH 2007
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- G. Lozanski B. Sanford K. Mrozek C. Edwards R. Pearson C. D. Bloomfield R. A. Larson W. Stock
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-10102, CALGB-8461, CALGB-9665, CALGB-9862
- Phases:
- 1/2, N/A
- Keywords: